Academic Journal

Molecular and clinical epidemiology of carbapenem resistant Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacterales in Fiji: a multicentre prospective observational studyResearch in context

التفاصيل البيبلوغرافية
العنوان: Molecular and clinical epidemiology of carbapenem resistant Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacterales in Fiji: a multicentre prospective observational studyResearch in context
المؤلفون: Sakiusa C. Baleivanualala, Silivia Matanitobua, Vika Soqo, Shayal Smita, Josese Limaono, Sajnel C. Sharma, Swastika V. Devi, Lusiana V. Boseiwaqa, Numa Vera, Silpa Kumar, Amele Lalibuli, Josese Mailulu, Donald Wilson, Yvette Samisoni, John A. Crump, James E. Ussher
المصدر: The Lancet Regional Health. Western Pacific, Vol 47, Iss , Pp 101095- (2024)
بيانات النشر: Elsevier, 2024.
سنة النشر: 2024
المجموعة: LCC:Public aspects of medicine
مصطلحات موضوعية: Carbapenem resistant, Acinetobacter baumannii, Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae, Public aspects of medicine, RA1-1270
الوصف: Summary: Background: Carbapenem resistant organisms (CROs) such as Acinetobacter baumannii (CRAb), Pseudomonas aeruginosa (CRPa), Escherichia coli (CREc), and Klebsiella pneumoniae (CRKp) have been identified by the World Health Organization (WHO) as global priority pathogens. The dissemination of these pathogens and clonal outbreaks within healthcare facilities are of serious concern, particularly in regions with limited resources. In Fiji, where healthcare services are primarily provided by public hospitals, understanding the extent and nature of this problem is essential for the development of effective patient management, prevention interventions and control strategies. Methods: CROs isolated from 211 (77.3%) non-sterile (urinary catheters, urine, sputum, wound swab, and endotracheal tube) and 62 (22.7%) normally sterile (blood, cerebrospinal fluid, intravascular catheter, and aspirates) body sites of 272 patients treated at the three major hospitals in Fiji, the Colonial War Memorial Hospital (CWMH), Lautoka Hospital (LTKH), and Labasa Hospital (LBSH), and outer peripheral health centres around Fiji, were analysed. Clinical and demographic patient data such as age, sex, admission diagnosis, admission and discharge dates, patient outcomes, date of death, start and end date of meropenem and colistin treatment were reviewed. These CRO isolates comprised A. baumannii, P. aeruginosa, E. coli, and K. pneumoniae, that were prospectively collected at the microbiology laboratory of CWMH and LBSH from January 2020 through August 2021 and at the LTKH from January 2020 to December 2021. In addition, 10 retrospectively stored CRPa isolates collected from patients at the CWMH from January through December 2019, were also included in the study. All isolates were characterised using mass spectrometry, antimicrobial susceptibility testing, and whole genome sequencing. Phylogenetic relationships among the CROs were assessed through core genome single nucleotide polymorphism (SNP) analysis. The CRAb isolates were also compared to the CRAb isolates from CWMH isolated in 2016/2017 and 2019, along with CRAb isolates obtained from Fijian patients admitted to New Zealand hospitals in 2020 and 2021 from our retrospective study. Findings: Of 272 patients, 140 (51.5%) were male, the median (range) age of patients was 45 (
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 2666-6065
Relation: http://www.sciencedirect.com/science/article/pii/S2666606524000890; https://doaj.org/toc/2666-6065
DOI: 10.1016/j.lanwpc.2024.101095
URL الوصول: https://doaj.org/article/5b74e89a77a1420d875672cbbb91114f
رقم الانضمام: edsdoj.5b74e89a77a1420d875672cbbb91114f
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:26666065
DOI:10.1016/j.lanwpc.2024.101095